
Brian Druker, M.D. (2017)
Brian Druker, M.D., Knight Cancer Institute director, JELD-WEN Chair of Leukemia Research. (OHSU/Kristyna Wentz-Graff)

AML study
(Left to right) Shannon McWeeney, Ph.D., Jeff Tyner, Ph.D. and Cristina Tognon, Ph.D., part of an OHSU research team that published the largest cancer dataset of its kind. (OHSU/Kristyna Wentz-Graff)

AML study
(Left to right) Shannon McWeeney, Ph.D., Jeff Tyner, Ph.D. and Cristina Tognon, Ph.D., part of an OHSU research team that published the largest cancer dataset of its kind. (OHSU/Kristyna Wentz-Graff)

AML study
(Left to right) Beth Wilmot, Ph.D., Libbey White, M.F.A., Daniel Bottomly, M.S., and Stephen Kurtz, Ph.D., part of an OHSU research team created a new data visualization tool, utilizing the largest cancer dataset of its kind. (OHSU/Kristyna Wentz-Graff)

Cristina Tognon, Ph.D. (2018)
Cristina Tognon, Ph.D., scientific director of the Druker lab at the Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jeff Tyner, Ph.D. (2018)
Jeff Tyner, Ph.D., associate professor in the OHSU School of Medicine department of Cell, Developmental & Cancer Biology and researcher with the OHSU Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jeff Tyner, Ph.D. (2018)
Jeff Tyner, Ph.D., associate professor in the OHSU School of Medicine department of Cell, Developmental & Cancer Biology and researcher with the OHSU Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Shannon McWeeney, Ph.D. (2018)
Shannon McWeeney, Ph.D., professor and head of the Division of Bioinformatics and Computational Biology and an OHU Knight Cancer Institute researcher, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jerry Widawski new puppy
Susan and Jerry Widawski hold their new puppy. More than two years since his last chemotherapy infusion, Jerry Widawski is cancer-free. (Courtesy of the Widawskis)
